Ishwarya Thyagarajan's Profile

Masters in Development

Ishwarya Thyagarajan

After pursuing a Master's in Development from Azim Premji University, Ishwarya was working as a Research Associate with Massachusetts Institute of Technology studying gender and institutions of family and marriage before joining MOHAN Foundation. At MOHAN Foundation she is a Helpline Executive view more..

Written / Edited / Medically Reviewed

 Antioxidant Compound Could Help Prevent Acute Kidney Failure

Antioxidant Compound Could Help Prevent Acute Kidney Failure

Acute kidney failure can be treated with antioxidants. Peroxiredoxin, an antioxidant compound is effective in treating kidney injuries and also may offer likelihoods of longer kidney transplant storage.

Health In Focus
Kidney Transplants Between People With HIV Offer Long-term Success

Kidney Transplants Between People With HIV Offer Long-term Success

Overall survival and kidney graft survival rates of HIV-infected patients who received kidney transplants from deceased donors with HIV have been high even after five years. The findings of this study may help in improving the health of many with HIV having kidney diseases.

Health In Focus
 Opt-out Organ Donation Could Affect Transplant Waitlists

Opt-out Organ Donation Could Affect Transplant Waitlists

A policy shift to adopt presumed consent from the current opt-in system could benefit the organ donation situation in the United States. Another way to increase the donor pool is to break down barriers to the living donation of kidneys and livers.

Health In Focus
 Home Dialysis can Improve Quality of Life for Kidney Disease Patients

Home Dialysis can Improve Quality of Life for Kidney Disease Patients

At-home dialysis option is safe to be expanded to use in large, integrated health care systems as it offers improved outcomes for patients with chronic kidney disease (CKD).

Health In Focus
New Drug Combination may Extend the Lives of Lung Transplant Patients

New Drug Combination may Extend the Lives of Lung Transplant Patients

A new drug combination with the potential to extend patient survival in lung transplant recipients has been identified. Sirolimus plus Tacrolimus combination helps in the long-term prevention of chronic rejection. Further studies would be required to investigate optimal dosages of the drugs to treat the patients.

Health In Focus